Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07418502 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pressure Targeting During High Flow Therapy in Premature Infants

Study acronym: NeoMATCH
StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The goal of this study is to see if a new approach to breathing support ('Pressure Targeted High Flow') is as effective as standard of care ('Continuous Positive Airway Pressure') in prematurely born infants. It will also learn about the effect of these types of breathing support on infant comfort and impact on staffing. The main question it aims to answer is: Does Pressure Targeted High Flow provide enough support in premature infants? Participants will: Take spend 24 hours supported by Pressure Targeted High Flow and 24 hours supported by CPAP. During this time their breathing rate, oxygen requirement and other markers of comfort will be monitored.
Trial Details
NCT Number NCT07418502
Lead Sponsor University of Texas at Austin
Collaborators: Sharp Mary Birch Hospital for Women & Newborns
Conditions
(from sponsor)		 Preterm Infants, Respiratory Distress Syndrome (Neonatal), BPD - Bronchopulmonary Dysplasia
Related terms Bronchopulmonary Dysplasia, Premature Birth, Pulmonary Atelectasis
Enrollment 78 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov